Electroceuticals Medicine Market by Type (Implantable Electroceutical Device and Non-invasive Electroceutical Devices), Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Treatment Resistant Depression, Epilepsy, Urinary and Fecal Incontinence, and Others), Product (Implantable Cardioverter Defibrillators, Cardiac Pacemaker, Cochlear Implant, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Others), and End User (Hospitals, Research Institutes, Individual Users, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
|
A06258
|
Pages: NA
|
Jul 2020 |
50 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Electroceuticals Medicine Market
Request Now !Electroceuticals are the therapeutic agents that act on the neural circuits of the organs. Unlike conventional drugs, these drugs target discrete neural electrical circuits in the cells thus making it a precise medication for the treatment. Thus, they are considered to be an alternative for the pharmaceutical drug-based remedies. Electroceuticals make use of neuroscience, electronics, bioengineering, and molecular medicines for regulating the biological processes in human body. These are used in treating various diseases namely; cardiovascular diseases, rheumatoid arthritis, diabetes, paralysis,and epilepsy.
Rise in prevalence and incidences of neurological disorders along with increased cost pressures of pharmaceutical drugs are anticipated to drive the electroceuticals market in the coming future. Moreover, rise in geriatric population and increase in investments for development of electroceuticals are expected to further boost the electroceuticals medicine market growth. However, the possibility of the targeted impulse might stimulate the other surrounding nerves and the complexity of the neural network is expected to hamper the growth of the market across the globe. In addition, higher costs of implants retrain the growth of the market in the coming years. Furthermore, presence of pipeline products is providing newer opportunities for the growth of the market in developed as well as developing countries.
The electroceuticals medicine market can be segmented on the basis of application, route of administration, distribution channel, and region. Based on type, the market can be bifurcated into implantable electroceutical and non-invasive electroceutical devices. Based on application, it is divided into arrhythmia, pain management, sensorineural hearing loss, Parkinson’s disease, tremor, depression, treatment resistant depression, epilepsy, urinary and fecal incontinence, and others. On the basis ofproduct, the market is classified into implantable cardioverter defibrillators, cardiac pacemaker, cochlear implant, spinal cord stimulators, deep brain stimulators, transcutaneous electrical nerve stimulators, sacralnerve stimulator, vagus nerve stimulator, and others. Based on end user, the electroceuticals medicine market is divided into hospitals, research institutes, individual users, and others. Region wise, it is analyzed across North America, Asia-Pacific, Europe, and LAMEA.
The prominent players in the market have adopted various strategies for increasing theirelectroceuticals medicine market share. These include expansion of their geographical presence through collaborations and partnerships and increase in investment in developing long acting and effective products with lower adverse effects. Major players operating in the electroceuticals medicine market includeBoston Scientific Corporation, Medtronic plc, Cochlear Limited, Biotronik, LivaNova PLC, ElectroCore LLC, Vomaris Innovations, Inc., BioElectronics Corporation, Oticon Medical, and NeuroSigma, Inc. Some of the other players operating in the market are St. Jude Medical, Inc., Sonova Holding AG, EnteroMedics Inc., Nevro Corporation, Cefaly Technology, and Stimwave LLC.
Key Benefits For Stakeholders
-
This report provides a detailed quantitative analysis of the current electroceuticals medicine market trends and forecast estimations from 2019 to 2027, which assists to identify the prevailing electroceuticals medicine market opportunities.
-
An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
-
A comprehensive analysis of the factors that drive and restrain the growth of the global electroceuticals medicine market is provided.
-
Region-wise and country-wise electroceuticals medicine market conditions are comprehensively analyzed in this report.
-
The projections in this report are made by analyzing the current electroceuticals medicine market trends and future market potential from 2019 to 2027 in terms of value.
-
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
-
The key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of global market.
Key Market Segments
By Type
- Implantable Electroceutical Device
- Non-invasive Electroceutical Devices
By Application
- Arrhythmia
- Pain Management
- Sensorineural Hearing Loss
- Parkinson’s Disease
- Tremor
- Depression
- Treatment Resistant Depression
- Epilepsy
- Urinary and Fecal Incontinence
- Others
By Product
- Implantable Cardioverter Defibrillators
- Cardiac Pacemaker
- Cochlear Implant
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Transcutaneous Electrical Nerve Stimulators
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Others
By End User
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
Electroceuticals Medicine Market
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.